These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 17967852

  • 1. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
    Park YS, Shin WS, Kim SK.
    J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
    [Abstract] [Full Text] [Related]

  • 2. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.
    J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD, Citron DM.
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [Abstract] [Full Text] [Related]

  • 5. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 7. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
    Patel MV, De Souza NJ, Gupte SV, Jafri MA, Bhagwat SS, Chugh Y, Khorakiwala HF, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR, Rhomberg PR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [Abstract] [Full Text] [Related]

  • 9. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW.
    Clin Infect Dis; 2009 Oct 15; 49(8):1169-74. PubMed ID: 19769538
    [Abstract] [Full Text] [Related]

  • 10. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T.
    Int J Antimicrob Agents; 2011 Mar 15; 37(3):219-24. PubMed ID: 21239146
    [Abstract] [Full Text] [Related]

  • 11. In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus.
    Tsuji BT, Yang JC, Forrest A, Kelchlin PA, Smith PF.
    J Antimicrob Chemother; 2008 Jul 15; 62(1):156-60. PubMed ID: 18400804
    [Abstract] [Full Text] [Related]

  • 12. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G, Moellering RC.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [Abstract] [Full Text] [Related]

  • 13. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D, Toshkova K, Gavrilova V.
    Vutr Boles; 2000 Jun 01; 32(2):35-40. PubMed ID: 11227664
    [Abstract] [Full Text] [Related]

  • 14. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM, Boyle-Vavra S, Shete PB, Daum RS.
    J Infect Dis; 2002 Sep 01; 186(5):661-7. PubMed ID: 12195353
    [Abstract] [Full Text] [Related]

  • 15. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
    Udo EE, Al-Sweih N, Dhar R, Dimitrov TS, Mokaddas EM, Johny M, Al-Obaid IA, Gomaa HH, Mobasher LA, Rotimi VO, Al-Asar A.
    Med Princ Pract; 2008 Sep 01; 17(1):71-5. PubMed ID: 18059105
    [Abstract] [Full Text] [Related]

  • 16. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb 01; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 17. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS, Tulkens PM, Van Bambeke F, Frimodt-Møller N, Høiby N, Kristensen HH.
    J Antimicrob Chemother; 2010 Aug 01; 65(8):1720-4. PubMed ID: 20534628
    [Abstract] [Full Text] [Related]

  • 18. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE, Poppens PT.
    J Antimicrob Chemother; 2009 Mar 01; 63(3):485-8. PubMed ID: 19109338
    [Abstract] [Full Text] [Related]

  • 19. Glycopeptide and oxacillin activity against Staphylococcus aureus isolates at a tertiary care center in Lebanon.
    Kanj SS, Ghaleb PA, Araj GF.
    J Med Liban; 2004 Mar 01; 52(1):8-12. PubMed ID: 15881695
    [Abstract] [Full Text] [Related]

  • 20. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G.
    Antimicrob Agents Chemother; 2007 Sep 01; 51(9):3397-400. PubMed ID: 17591849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.